From age to previous exposure to radiation therapy, know the main causes that can trigger the development of sarcoma.

Doxorubicin Hydrochloride Liposome Injection is indicated for the treatment of ovarian Cancer, AIDS-Related Kaposi's sarcoma, and multiple myeloma, the company said. Citing IQVIA data, Alembic said ...

USFDA approves Alembic Pharmaceuticals' generic Doxorubicin Hydrochloride Liposome injection for various cancers, equivalent ...

Alembic Pharmaceuticals receives USFDA approval for its generic Doxorubicin Hydrochloride Liposome Injection used to treat ...

Alembic Pharmaceuticals has secured final USFDA approval for its generic version of Doxorubicin Hydrochloride Liposome, a ...

Mumbai: Shares of Alembic Pharmaceuticals surged 13.61 percent on Monday after a major regulatory approval. The stock hit a ...

According to IQVIA, the market for Doxorubicin Hydrochloride Liposome Injection is estimated at $29 million for the twelve months ending March 2025.

Alembic Pharmaceuticals shares surged over 12 per cent after receiving USFDA approval for its generic Doxorubicin ...

The approved ANDA is for the 20mg/10 ml (2mg/ml) and 50 mg/25 ml (2mg/ml) strength single-dose vials. It is therapeutically ...

The company received USFDA approval for Doxorubicin Hydrochloride Injection, which will be use for the treatment of Ovarian ...

The refrain heard during the 2024 Democratic National Convention was: “We Won’t Go Back.” It was a warning many assumed ...

Future Microbiology Instigation of Notch Signaling in the Pathogenesis of Kaposi's Sarcoma-associated Herpesvirus and Other Human Tumor Viruses ...